Next Article in Journal
Assessment of Aptamer as a Potential Drug Targeted Delivery for Retinal Angiogenesis Inhibition
Next Article in Special Issue
High-Density Lipoprotein in Metabolic Disorders and Beyond: An Exciting New World Full of Challenges and Opportunities
Previous Article in Journal
S-72, a Novel Orally Available Tubulin Inhibitor, Overcomes Paclitaxel Resistance via Inactivation of the STING Pathway in Breast Cancer
Previous Article in Special Issue
Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
 
 
Review

Article Versions Notes

Pharmaceuticals 2023, 16(5), 750; https://doi.org/10.3390/ph16050750
Action Date Notes Link
article xml file uploaded 16 May 2023 07:37 CEST Original file -
article xml uploaded. 16 May 2023 07:37 CEST Update https://www.mdpi.com/1424-8247/16/5/750/xml
article pdf uploaded. 16 May 2023 07:37 CEST Version of Record https://www.mdpi.com/1424-8247/16/5/750/pdf
article html file updated 16 May 2023 07:38 CEST Original file https://www.mdpi.com/1424-8247/16/5/750/html
Back to TopTop